Alan J. Garber

1972–2020 年に発表

52
論文数
29,583
被引用数
52
h 指数
52
i10 指数

被引用数

Alan J. Garber の年別被引用数1974 年: 被引用 5 件1975 年: 被引用 1 件1976 年: 被引用 7 件1977 年: 被引用 1 件1978 年: 被引用 6 件1979 年: 被引用 1 件1980 年: 被引用 1 件1981 年: 被引用 3 件1982 年: 被引用 2 件1983 年: 被引用 2 件1985 年: 被引用 2 件1986 年: 被引用 2 件1987 年: 被引用 3 件1988 年: 被引用 1 件1989 年: 被引用 2 件1990 年: 被引用 2 件1991 年: 被引用 2 件1992 年: 被引用 4 件1993 年: 被引用 1 件1994 年: 被引用 3 件1995 年: 被引用 1 件1996 年: 被引用 1 件1997 年: 被引用 4 件1998 年: 被引用 1 件1999 年: 被引用 11 件2000 年: 被引用 7 件2001 年: 被引用 2 件2002 年: 被引用 18 件2003 年: 被引用 56 件2004 年: 被引用 96 件2005 年: 被引用 167 件2006 年: 被引用 191 件2007 年: 被引用 211 件2008 年: 被引用 229 件2009 年: 被引用 275 件2010 年: 被引用 249 件2011 年: 被引用 295 件2012 年: 被引用 309 件2013 年: 被引用 304 件2014 年: 被引用 226 件2015 年: 被引用 220 件2016 年: 被引用 212 件2017 年: 被引用 236 件2018 年: 被引用 256 件2019 年: 被引用 853 件2020 年: 被引用 772 件2021 年: 被引用 575 件2022 年: 被引用 426 件2023 年: 被引用 309 件2024 年: 被引用 458 件2025 年: 被引用 243 件2026 年: 被引用 10 件1984 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,053 件、この内訳の 27.2%イギリス: 引用元論文 756 件、この内訳の 6.7%中国: 引用元論文 706 件、この内訳の 6.3%イタリア: 引用元論文 562 件、この内訳の 5%カナダ: 引用元論文 496 件、この内訳の 4.4%ドイツ: 引用元論文 454 件、この内訳の 4.1%オーストラリア: 引用元論文 367 件、この内訳の 3.3%スペイン: 引用元論文 330 件、この内訳の 2.9%デンマーク: 引用元論文 305 件、この内訳の 2.7%フランス: 引用元論文 298 件、この内訳の 2.7%オランダ: 引用元論文 284 件、この内訳の 2.5%日本: 引用元論文 248 件、この内訳の 2.2%
0%27.2%その他 30%

分野

  • Medicine85%
  • Biochemistry, Genetics and Molecular Biology7.5%
  • Health Professions2.4%
  • Nursing0.8%
  • Immunology and Microbiology0.6%
  • Neuroscience0.6%
  • その他3.1%

トピック

  • Diabetes Treatment and Management9%
  • Chronic Kidney Disease and Diabetes6%
  • Dialysis and Renal Disease Management4.3%
  • Diabetes Management and Research4%
  • Diabetes, Cardiovascular Risks, and Lipoproteins3.5%
  • Metabolism, Diabetes, and Cancer3.2%
  • その他70%

共著者

全論文

検索で開く
  1. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity

    著者: , , , , , , , , - Endocrine Practice 2016 被引用: 1,835

  2. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Garabed Eknoyan, Nathan W. Levin, S Burrows-Hudson, William F. Keane, Alan S. Kliger, Derrick L. Latos, Donna Mapes, Edith T. Oberley, Kerry Willis, George R. Bailie, Gavin J. Becker, Jerrilynn D. Burrowes, David Churchill, Alan Collins, William Couser, Dick de Zeeuw, Alan J. Garber, Thomas A. Golper, Frank A. Gotch, Antonio M. Gotto, Joel Greer, Richard H. Grimm, Ramon G. Hannah, Jaime Herrera Acosta, Ronald J. Hogg, Lawrence G. Hunsicker, Michael J. Klag, Saulo Klahr, C. Lewis, Edmund G. Lowrie, Arthur Matas, Sally D. McCulloch, Maureen Michael, Joseph V. Nally, John M. Newmann, Allen R. Nissenson, Keith C. Norris, William F. Owen, Thakor G. Patel, Glenda M. Payne, Rosa A. Rivera-Mizzoni, David L. Smith, Robert A. Star, Theodore I. Steinman, Fernando Valderrábano, John Walls, Jean Pierre Wauters, Nanette K. Wenger, Josephine P. Briggs - 2002 被引用: 11,656

  3. Metabolic Syndrome

    著者: , - Endocrinology and Metabolism Clinics of North America 2014 被引用: 739

  4. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Donald A. Smith, Kathleen Wyne, Michael A. Bush, Farhad Zangeneh, Yehuda Handelsman, David S.H. Bell, Zachary T. Bloomgarden, Eliot A. Brinton, Sergio Fazio, Vivian Fonseca, Alan J. Garber, George Grunberger, Chris Guerin, Paul S. Jellinger, Paul D. Rosenblit, Donald A. Smith, Kathleen Wyne, Michael H. Davidson - Endocrine Practice 2017 被引用: 1,098

  5. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm – 2020 Executive Summary

    著者: , , , , , , , , , , , , , , , , - Endocrine Practice 2020 被引用: 248

  6. Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial

    著者: , , , , , , , , - The Lancet 2008 被引用: 1,053

  7. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary

    著者: , , , , , , , , , , , , , , , , , , - Endocrine Practice 2020 被引用: 603

  8. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of SGLT-2 Inhibitors and Diabetic Ketoacidosis

    著者: , , , , , , , , , , , , - Endocrine Practice 2016 被引用: 357

  9. Long-Acting Glucagon-Like Peptide 1 Receptor Agonists

    著者: - Diabetes Care 2011 被引用: 349

  10. Efficacy of Metformin in Type II Diabetes

    著者: , , , , - The American Journal of Medicine 1997 被引用: 525

  11. Comparison Of The Long-Term Effects Of Liraglutide And Glimepiride Monotherapy On Bone Mineral Density In Patients With Type 2 Diabetes

    著者: , , , , , , - Endocrine Practice 2015 被引用: 75

  12. Consensus Statement By The American Association Of Clinical Endocrinologists And American College Of Endocrinology On The Comprehensive Type 2 Diabetes Management Algorithm – 2016 EXECUTIVE SUMMARY

    著者: , , , , , , , , , , , , , , , , , , , , - Endocrine Practice 2016 被引用: 875

  13. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary

    著者: , , , , , , , , , , , , , , , , , , , - Endocrine Practice 2018 被引用: 505

  14. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2019 Executive Summary

    著者: , , , , , , , , , , , , , , , , , , , - Endocrine Practice 2019 被引用: 298

  15. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive type 2 Diabetes Management Algorithm – 2017 Executive Summary

    著者: , , , , , , , , , , , , , , , , , , , - Endocrine Practice 2017 被引用: 435

  16. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the 2014 Advanced Framework for a New Diagnosis of Obesity as a Chronic Disease

    著者: , , , , , , , , , , , , - Endocrine Practice 2014 被引用: 235

  17. Liraglutide Treatment Is Associated with a Low Frequency and Magnitude of Antibody Formation with No Apparent Impact on Glycemic Response or Increased Frequency of Adverse Events: Results from the Liraglutide Effect and Action in Diabetes (LEAD) Trials

    著者: , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2011 被引用: 150

  18. The Clinical Approach to the Detection of Lipodystrophy an Aace Consensus Statement

    著者: , , , , , , , , , , , , , - Endocrine Practice 2013 被引用: 121

  19. American Association Of Clinical Endocrinologists And American College Of Endocrinology -Clinical Practice Guidelines For Developing A Diabetes Mellitus Comprehensive Care Plan – 2015

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul D. Rosenblit, Aaron I. Vinik, Kathleen Wyne, Farhad Zangeneh - Endocrine Practice 2015 被引用: 566

  20. American Association of Clinical Endocrinologists’ Position Statement on Obesity and Obesity Medicine

    著者: , , , , , , , , , , , , - Endocrine Practice 2012 被引用: 160

  21. Statement by an American Association of Clinical Endocrinologists/ American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic Control

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Endocrine Practice 2009 被引用: 947

  22. Dysglycemia-Based Chronic Disease: An American Association of Clinical Endocrinologists Position Statement

    著者: , , , , - Endocrine Practice 2018 被引用: 103

  23. Clinical Practice Guidelines for Healthy Eating for the Prevention and Treatment of Metabolic and Endocrine Diseases in Adults: Cosponsored by the American Association of Clinical Endocrinologists/The American College of Endocrinology and the Obesity Society

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , George Grunberger, Richard Haas, Yehuda Handelsman, R. Mack Harrell, Howard M. Lando, Matthew J. LeVine, Angelo A. Licata, Janet B. McGill, Molly McMahon, Elizabeth Pearce, Rachel Pessah‐Pollack, Herbert I. Rettinger, Donna H. Ryan, George E. Shambaugh, Vin Tangpricha, Asha Thomas, J L Palancar de la Torre, Sandra Weber, Daniel Weiss - Endocrine Practice 2013 被引用: 97

  24. American Association of Clinical Endocrinologists and American College of Endocrinology – Clinical Practice Guidelines for Developing A Diabetes Mellitus Comprehensive Care Plan – 2015 — Executive Summary

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul D. Rosenblit, Aaron I. Vinik, Kathleen Wyne, Farhad Zangeneh - Endocrine Practice 2015 被引用: 635